4.7 Review

MicroRNAs: emerging driver of cancer perineural invasion

Journal

CELL AND BIOSCIENCE
Volume 11, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13578-021-00630-4

Keywords

Perineural invasion; Malignant tumors; MicroRNA; Biomarkers

Funding

  1. National Natural Science Foundation of China [81972542, 82073000, 81902779]
  2. National Science Foundation of Sichuan Province [2020JDRC0018, 2020YFS0171]
  3. Clinical Research Project of West China Hospital of Stomatology, Sichuan University [LCYJ2019-8]

Ask authors/readers for more resources

Perineural invasion (PNI) is a common clinical feature in malignant tumors that can lead to postoperative recurrence and metastasis. Recent studies have shown that miRNA plays a crucial role in regulating PNI, offering potential new biomarkers and therapeutic targets for cancer treatment.
The perineural invasion (PNI), which refers to tumor cells encroaching on nerve, is a clinical feature frequently occurred in various malignant tumors, and responsible for postoperative recurrence, metastasis and decreased survival. The pathogenesis of PNI switches from 'low-resistance channel' hypothesis to 'mutual attraction' theory between peripheral nerves and tumor cells in perineural niche. Among various molecules in perineural niche, microRNA (miRNA) as an emerging modulator of PNI through generating RNA-induced silencing complex (RISC) to orchestrate oncogene and anti-oncogene has aroused a wide attention. This article systematically reviewed the role of microRNA in PNI, promising to identify new biomarkers and offer cancer therapeutic targets.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available